These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2909290)

  • 1. Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma.
    Petrelli NJ; Madejewicz S; Rustum Y; Herrera L; Creaven PJ; Plager J; Soloman J; Mittelman A
    Cancer Chemother Pharmacol; 1989; 23(1):57-60. PubMed ID: 2909290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
    Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY
    Oncology; 2002; 63(3):239-47. PubMed ID: 12381903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.
    LoRusso P; Pazdur R; Redman BG; Kinzie J; Vaitkevicius V
    Am J Clin Oncol; 1989 Dec; 12(6):486-90. PubMed ID: 2686394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinoma.
    Scheithauer W; Depisch D; Schiessel R; Ludwig H
    Oncology; 1989; 46(4):217-21. PubMed ID: 2787010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma.
    Posner M; Slapak CA; Browne MJ; Clark JW; Curt G; Weitberg A; Calabresi P; Cummings FJ; Wiemann M; Urba S
    Am J Clin Oncol; 1990 Oct; 13(5):455-8. PubMed ID: 2220666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer.
    Wu XY; Huang XE; You SX; Lu YY; Cao J; Liu J
    Asian Pac J Cancer Prev; 2013; 14(3):2019-22. PubMed ID: 23679311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II trial of 5-fluorouracil and etoposide in metastatic colorectal carcinoma.
    Zelkowitz RS; Posner MR; Cummings F; Beitz J; Weitberg AB
    Am J Clin Oncol; 1989 Dec; 12(6):491-3. PubMed ID: 2589229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group study.
    Whitehead RP; Fleming TR; Macdonald JS; Ahmann FR; Garewal HS; Kuebler JP
    Invest New Drugs; 1991 Nov; 9(4):345-7. PubMed ID: 1804811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group study.
    Bleiberg H; Vanderlinden B; Buyse M; Haegele P; Paillot B; Tagnon A; Wils J; Cartei G; Fornasiero A; Duez N
    Cancer Invest; 1990; 8(5):471-5. PubMed ID: 2265371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
    Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
    J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.
    Cazap EL; Gisselbrecht C; Smith FP; Estevez RA; Alvarez CA; Lagarde C; Hannois A; Ahmed S; Schein PS; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):781-3. PubMed ID: 3524826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
    Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
    Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
    Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.